Announcing IndieBio SF’s Next Wave – VC-Founder Meetings (June 17 to 21) Learn More

Xias Bio Limited

Replacing Animal Proteins


David Harvey

CEO & Co-Founder

Alister Minty


Faadil Fawzy

Co-Founder & Chief Scientific Officer

Company details

The $500 billion personal care and cosmetics industry is alarmingly reliant on raw materials from livestock. The three most important proteins in skincare and haircare products—collagen, keratin, and elastin—typically come from bovine hides, chicken feathers, and meat processing byproducts, respectively. Thus, cosmetics contribute to greenhouse gas emissions, water pollution, and deforestation. With two-thirds of consumers demanding cleaner beauty ingredients, the industry faces immense pressure to replace animal proteins with sustainable, cost-competitive alternatives.

Xias Bio has developed the world’s first molecular platform for creating multi-functional, animal-free proteins. Each one can do the work of three or more animal proteins. Xias licenses its proteins for manufacture to suppliers of global cosmetics, making industry adoption quick and easy. The Xias platform already has 2.6 million different proteins in its library, all of which can be made using the same modular, Lego-like base molecule and fermentation process.

Founded in Glasgow, Scotland by Dr. David Harvey, Dr. Faadil Fawzy, and Alister Minty, Xias brings over 20 years combined experience in protein design. The company has licensed its multi-function proteins to major leaders in the cosmetics industry. Though currently focused on cosmetics, Xias aims to replace animal proteins throughout the bioeconomy, from pharmaceuticals and therapeutics to AgTech and the food industry.

Get In Touch with Xias Bio Limited

Please tell us a little bit about yourself and why you'd like to get connected. Xias Bio Limited + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.